Amsterdam University Medical Centres, University of Amsterdam, Center of Experimental and Molecular Medicine & Division of Infectious Diseases, Amsterdam, the Netherlands.
Amsterdam University Medical Centres, University of Amsterdam, Center of Experimental and Molecular Medicine & Division of Infectious Diseases, Amsterdam, the Netherlands.
EBioMedicine. 2022 Dec;86:104363. doi: 10.1016/j.ebiom.2022.104363. Epub 2022 Dec 2.
Sepsis is an ill-defined syndrome yet is a leading cause of morbidity and mortality worldwide. The most recent consensus defines sepsis as life-threatening organ dysfunction caused by a dysregulated host response to infection. However, this definition belies the complexity and breadth of immune mechanisms involved in sepsis, which are characterized by simultaneous hyperinflammation and immune suppression. In this review, we describe the immunopathogenesis of sepsis and highlight some recent pathophysiological findings that have expanded our understanding of sepsis. Sepsis endotypes can be used to divide sepsis patients in different groups with distinct immune profiles and outcomes. We also summarize evidence on the role of the gut microbiome in sepsis immunity. The challenge of the coming years will be to translate our increasing knowledge about the molecular mechanisms underlying sepsis into therapies that improve relevant patient outcomes.
脓毒症是一种定义不明确的综合征,但却是全球发病率和死亡率的主要原因。最近的共识将脓毒症定义为感染引起的宿主反应失调导致的危及生命的器官功能障碍。然而,这一定义掩盖了脓毒症所涉及的免疫机制的复杂性和广泛性,其特征是同时存在过度炎症和免疫抑制。在这篇综述中,我们描述了脓毒症的免疫发病机制,并强调了一些最近的病理生理学发现,这些发现扩展了我们对脓毒症的理解。脓毒症的表型可以用于将脓毒症患者分为具有不同免疫特征和结局的不同组。我们还总结了肠道微生物组在脓毒症免疫中的作用的证据。未来几年的挑战将是将我们对脓毒症潜在分子机制的日益增长的认识转化为改善相关患者结局的治疗方法。